Skip to main content
. 2023 Mar 12;11(3):632. doi: 10.3390/vaccines11030632

Table 5.

Laboratory findings and outcomes of patients with moderate–severe disease.

Parameters N = 26
WBC (cells/103) 7520 (4700–10,350)
Lymphocytes (cells/103) 640 (440–1020)
Ferritin (ng/mL) 652 (209–1063)
CRP (mg/L) 42 (16–69.1)
Hospitalization (n %) 21 (80.8)
COVID-19 related hospitalization (n %) 21 (100.0)
O2 treatment (n %) 18 (69.2)
AKI (n %) 3 (11.5)
ICU admission (n %) 5 (19.2)
Death (n %) 2 (7.7)

Abbreviations: WBC, white blood cells; CRP, C-reactive protein; COVID-19, corona-virus disease 2019; AKI, acute kidney injury; ICU, intensive care unit.